Rivastigmine - RIVASTIGMINE EG 4,6 mg/24 h, dispositif transdermique

Business Listing - December 25, 2019

Rivastigmine RIVASTIGMINE EG 4,6 mg/24 h, dispositif transdermique - N06DA03 EG LABO - LABORATOIRES EUROGENERICS - 64501892

This is a premium business listing. Stand out from the competition!

List your company and reach more customers today.